Evidence map›Paper›PMID 41438289›Full record

ReviewChemical science2026

Poly(beta-amino esters): applications in immunology.

Hulya Bayraktutan, Rafał J Kopiasz, Amr Elsherbeny, Pratik Gurnani, Cameron Alexander

Abstract readReview
In one paragraph

Review in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hulya BayraktutanDivision of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham Boots Science Building Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0000-0003-3818-2973
Rafał J KopiaszDivision of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham Boots Science Building Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0000-0001-8902-1761
Amr ElsherbenyDivision of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham Boots Science Building Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0000-0003-0437-4299
Pratik GurnaniUCL School of Pharmacy, University College London 29-39 Brunswick Square, Bloomsbury London WC1N 1AX UK.ORCID https://orcid.org/0000-0002-6559-5514
Cameron AlexanderDivision of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham Boots Science Building Nottingham NG7 2RD UK cameron.alexander@nottingham.ac.uk.ORCID https://orcid.org/0000-0001-8337-1875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune system is critical in safeguarding human health against a variety of external and internal threats, yet its dysregulation can lead to serious diseases such as autoimmune disorders and cancers. However, recent years have witnessed notable progress in immunotherapeutic interventions, including the development of novel modalities such as messenger RNA and DNA vaccines, immunotherapies using immune checkpoint inhibitors, and personalised dendritic cell vaccines. To optimise the delivery of these promising therapies, there is a growing interest in understanding how to target efficiently immune cells and immune-rich organs. Among the various delivery systems explored, synthetic polymers have emerged as versatile platforms, offering tuneable properties to modulate the immune system effectively. Poly(beta-amino esters) (PBAEs), characterised by their pH-dependent degradability and nanoparticle-forming capabilities, have gained significant attention as a promising delivery system in immunotherapy, immune-oncology, and vaccination. This review evaluates recent advances and applications of PBAEs in immunology. Beginning with an overview of synthetic methodologies, we cover their utilisation for nucleic acid, small molecule, and protein delivery, addressing therapeutic challenges associated with the immune system. We explore the diverse monomer chemistries employed in these applications and evaluate PBAEs in cutting-edge approaches such as mRNA and DNA vaccines, cancer immunotherapies, and immune cell reprogramming. By evaluating existing literature, this review aims to provide insights into the potential of PBAEs in immunotherapy while defining future directions for exploration in this rapidly evolving field.

Identifiers

PMID41438289
PMCPMC12720461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.